Kairos Pharma KAPA
NYSE KAPA
$0.54 -0.03 (-5.76%)
As of: Oct 22, 2026 · 3:50 PM EDT

Kairos Pharma (KAPA) Accounts Payables (2023 - 2025)

Updated

Kairos Pharma's Accounts Payables was $199,000 in Q4 2025, down 79.9% from $992,000 a year earlier.

Analysis

Kairos Pharma (KAPA) Accounts Payables (2023 - 2025) Analysis & Trends

From Q4 2023 onward, Kairos Pharma has reported Accounts Payables for 6 quarters.

  • In earlier years, Accounts Payables was $992,000 in FY2024 (-58.7%) and $2.4 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 9.32 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 33.30 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 3.83 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 22.89 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 674.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 4.58 Bn
10 Kairos Pharma 10.01 Mn -2.40 Mn - 199,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 199,000.00
Jun 30, 2025 676,000.00
Mar 31, 2025 805,000.00
Dec 31, 2024 992,000.00
Sep 30, 2024 1.53 Mn
Dec 31, 2023 2.40 Mn
API Access

Kairos Pharma Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=KAPA&period=max&api_key=YOUR_API_KEY